What 20 Years of Supplement Formulation Taught Me About Sleep

Twenty years is a long time to spend inside any industry. Long enough to understand how things actually work rather than how they are presented as working. Long enough to see the same mistakes repeated by different companies in different market cycles. Long enough to develop a clear picture of the gap between what the science supports and what the market delivers, and to find that gap frustrating enough to want to do something about it.

Wulf Sleep is what I did about it. This is the honest version of how I got here.

What the Industry Looks Like From the Inside

The supplement industry is not monolithic. There are brands doing genuinely rigorous work, investing in clinical research, sourcing premium ingredients, making formulation decisions based on evidence rather than margin. I have worked alongside people like that for most of my career and they have shaped how I think about this work.

But the market is also full of the other kind. Products assembled from ingredient catalogues based on consumer search trends rather than physiological mechanisms. Proprietary blends that exist to obscure individual doses. Labels designed to impress rather than inform. Marketing that makes promises the formulation cannot keep.

In the sleep category specifically, the ratio has historically been very poor. Sleep supplements sell because the problem is universal and the desperation is real. A man who has not slept properly in two years will try almost anything, and the market has built an enormous business on that willingness to try, without an equivalent commitment to actually delivering results.

After two decades inside this industry, that dynamic stopped sitting well with me.

The Early Lessons: What Good Formulation Actually Is

The first thing twenty years taught me is that formulation is not about ingredients. It is about mechanisms.

An ingredient is a tool. The mechanism is the job the tool is supposed to do in the body. Most formulation decisions in the commercial supplement market are made at the ingredient level, this ingredient is associated with sleep, therefore include it. This ingredient is trending, therefore include it. This ingredient was in a study that showed positive outcomes, therefore include it.

The mechanism question, how exactly does this ingredient produce the outcome, at what dose, in what form, in what physiological context, and in combination with what other ingredients, is where the real formulation work happens. And it is where most commercial products stop asking questions.

I learned this early from watching the gap between what formulators knew and what products contained. You could read the same research a formulator had read to justify including an ingredient, and then look at the dose on the label and know that the mechanism could not engage at that level. The ingredient was there. The effect was not.

This is pixie dusting. It is endemic in the sleep category. And it is the reason a generation of men have concluded that sleep supplements don't work when the truth is that most sleep supplements are not dosed to work.

The ATP Science Years: Building at a Different Standard

We founded ATP Science at a time when most of what we were formulating did not exist in the Australian market. We were first to category on a significant number of products, which created a problem I did not fully anticipate: copycats.

In those early years we used proprietary blends. I want to be clear about why, because the context matters. It was not to hide underdosed ingredients, our formulations were expensive to produce precisely because they were dosed properly. It was to protect genuinely novel formulations from competitors who would have copied the ingredient names while swapping every premium form for a cheaper one. Magnesium glycinate on our label becomes magnesium oxide on theirs. The sleight of hand was using the same ingredient name — magnesium — but hiding or minimising the important part: what type of magnesium. A fraction of the bioavailability. Marketed as equivalent. That was the threat we were designing around, not direct imitation but label imitation, where the name is copied and the quality is not.

Looking back, I think we overestimated how many would have tried. The reality was that most competitors could not have made those formulations commercially viable even with a full view of our doses, because building to clinical standards at proper forms and doses produces a cost of goods that most brands building to a margin target simply cannot absorb. The quality itself was the moat. The proprietary blends were largely unnecessary, and full label transparency has been the standard ever since.

That realisation shaped how I think about label transparency now. Full disclosure is not a competitive risk when the product is genuinely built to a standard most brands cannot afford to match. The framework I developed during those years is simple: explain everything, dose everything correctly, never include an ingredient you cannot defend. It is the standard I hold every formulation to. Including Mr Wulf's.

Start with the physiology. Not the category. Not the marketing opportunity. The actual physiological problem and the cascade of events that need to occur for it to be resolved.

For sleep, that cascade is specific and well documented. Core body temperature must fall at sleep onset. The nervous system must transition from beta wave dominance to alpha wave relaxation. GABAergic inhibitory tone must be sufficient to dampen neuronal excitability. Cortisol must follow its natural declining curve into the evening. Melatonin must be produced by the pineal gland at adequate levels. Sleep must cycle through its five stages with adequate time in slow wave depth where the restorative processes are concentrated.

That is not one mechanism. It is six distinct physiological requirements, each with specific ingredients and specific doses that the research supports. A product that addresses only two of the six is not a sleep solution. It is a sleep supplement that short changes you and hopes you don't notice what is missing.

The ATP Science approach, explain everything, dose everything correctly, never include an ingredient you cannot defend, shaped the standard I hold every formulation to. Including my own.

What Twenty Years Taught Me About the Sleep Problem Specifically

Sleep deterioration in men over 30 is not random. It follows a predictable pattern driven by predictable physiological changes that accumulate with the lifestyle most high-performing men are living.

Chronic stress elevates cortisol. Cortisol stays elevated into the evening. Elevated evening cortisol suppresses melatonin production, keeps the HPA stress axis from standing down, and maintains a state of low-grade physiological alertness incompatible with the sleep onset sequence. The nervous system, trained by years of high-output professional and personal demands, defaults to operational mode and resists the transition to restorative mode even when the person is physically exhausted.

Magnesium helps calm the nervous system by supporting GABA signalling, stress response regulation, and sleep physiology, but chronic stress, hard training, alcohol, and ultra-processed diets can all increase the risk of falling short. The depletion worsens over time. The GABA system, already under pressure, loses a critical infrastructure component.

Training, particularly late training that elevates cortisol and body temperature in the hours before bed, adds another layer. The very behaviours that produce physical performance create physiological conditions that impair the sleep those behaviours require for recovery.

The result is a pattern I have seen described in almost identical terms by hundreds of men: hard to switch off at night, flat all day, waking at 2 or 3am with an alert quality that feels neurological rather than habitual, never fully recovering despite putting hours in bed, and finding that the single-ingredient supplements they have tried do not move the pattern.

Of course they don't. The pattern has six components. Single ingredients address one.

The Formulation Brief for Wulf Sleep

When I sat down to write the formulation brief for Wulf Sleep, I started by mapping every physiological mechanism involved in the failure pattern I had just described. Then I identified the ingredient with the strongest clinical evidence for each mechanism. Then I identified the dose used in the trials that produced positive outcomes. Then I built the product around those doses, in those forms, and ran it through a testing process to validate the combination.

The brief looked like this:

Mechanism: Core body temperature drop at sleep onset. Ingredient: Glycine. Form: amino acid. Clinical dose: 3000mg. Evidence: polysomnographic RCTs confirming reduced sleep onset latency and improved sleep efficiency from night one via peripheral vasodilation. Decision: 3000mg in the formula.

Mechanism: Evening cortisol reduction. Ingredient: Lactium® (alpha-casozepine). Form: patented bioactive peptide. Clinical dose: 200mg. Evidence: placebo-controlled trials confirming cortisol reduction and improved sleep efficiency in stressed adults. Decision: 200mg in the formula, using the genuine patented form.

Mechanism: Brainwave transition from beta to alpha. Ingredient: PharmaGABA™. Form: naturally fermented GABA via Lactobacillus hilgardii. Clinical dose: 100 to 130mg. Evidence: University of Shizuoka EEG trial confirming significant alpha wave increase and beta wave decrease within five minutes. Decision: 130mg of PharmaGABA™ specifically, not synthetic GABA.

Mechanism: Magnesium status and GABA-A receptor function. Ingredient: Magnesium Glycinate. Form: chelated. Not oxide, not citrate. Clinical dose: 1650mg at 20% elemental magnesium. Evidence: superior bioavailability, direct GABA-A receptor support, HPA axis regulation. Decision: 1650mg of the chelated form.

Mechanism: Cognitive hyperarousal and alpha wave support. Ingredient: L-Theanine. Clinical dose: 200mg. Evidence: 2025 meta-analysis across 19 RCTs confirming significant improvements in sleep onset latency and daytime dysfunction. Decision: 200mg.

Mechanism: Neuronal excitability and GABAergic inhibitory tone. Ingredient: Taurine. Clinical dose: 650mg. Evidence: inhibitory neuromodulator binding to GABA and glycine receptors; age-related decline associated with deteriorating sleep quality. Decision: 650mg.

Mechanism: GABA persistence through the sleep cycle. Ingredient: Lemon Balm at 5% rosmarinic acid. Clinical dose: 200mg. Evidence: GABA transaminase inhibition extending inhibitory signalling. Decision: 200mg standardised extract.

Mechanism: Direct GABA-A receptor binding. Ingredient: Chamomile at 3.2% apigenin. Clinical dose: 500mg standardised extract. Evidence: apigenin flavonoid binding at GABA-A receptor. Decision: 500mg at 3.2% standardisation.

Mechanism: Natural melatonin pathway support. Ingredient: Tart Cherry. Clinical dose: 1000mg. Evidence: natural melatonin and tryptophan content; Northumbria University RCT confirming improved sleep efficiency over seven days. Decision: 1000mg.

Mechanism: Deep, sustained calm through the sleep cycle. Ingredient: Ziziphus Spinosa at 2% standardisation. Clinical dose: 300mg. Evidence: traditional sedative activity with modern clinical evidence for sleep quality and daytime wellbeing. Decision: 300mg.

Ten ingredients. Ten mechanisms. Every one dosed where the research lives. That is what a clinical formulation brief looks like.

What We Removed, And Why That Matters Too

The formulation brief also described what did not make the final product. Three ingredients were in the original formula and removed after testing: Magnesium Threonate, Inositol, and Tryptophan.

All three have research behind them in sleep contexts. All three produced excitatory responses in a subset of our test group, the opposite of the intended effect.

Magnesium Threonate's superior blood-brain barrier penetration, which makes it attractive for cognitive applications, was the same property that increased neuronal activity in some participants rather than reducing it. Inositol's complex relationship with serotonergic pathways produced alerting rather than calming effects in a portion of the cohort. Tryptophan's conversion to serotonin before melatonin meant that individuals with already-adequate serotonin tone experienced stimulation rather than sedation.

These were expensive decisions. Magnesium Threonate costs more than Magnesium Glycinate. Removing tested ingredients from a formula adds cost and delays launch. But a sleep supplement that activates 30% of the people who take it is not a sleep supplement. The decisions were not difficult to make once the testing data was clear.

This is what separates a formulation process from a formulation brief on paper. The brief tells you what should work. The testing tells you what does.

The Lesson About Dose That Most Men Never Learn

The single most important thing I can tell any man who is evaluating a sleep supplement, including this one, is to look at the doses before you look at the ingredients.

The ingredient list is the marketing layer. The doses are the formulation layer. The gap between them is where most products are hiding their limitations.

If you see glycine at 500mg, you are not getting the mechanism that 3000mg produces. If you see magnesium at 100mg of oxide, you are not getting meaningful tissue repletion. If you see a proprietary blend listing eight ingredients in 600mg total, you are almost certainly getting pixie dusting across the board. If you see GABA without the PharmaGABA™ trademark, you may be getting synthetic GABA produced from pyrrolidinone, which Japan classifies as a dangerous substance, rather than the fermented form with EEG-confirmed clinical evidence.

These distinctions are not visible at the marketing level. They require reading the label like a formulator reads it. I am telling you how to do that because it is the only way to make an informed decision in a market that has not historically rewarded informed decisions.

Why I Built Wulf Sleep

Twenty years in this industry produces two outcomes. Either you become comfortable with the gap between what the science supports and what the market delivers, or you don't.

Wulf Sleep is the product I would have wanted to exist when I started understanding how sleep physiology actually works and how systematically the sleep supplement market was failing the people who needed it. Ten ingredients. Six mechanisms. Every dose at the clinical threshold. No melatonin. No sedatives. No proprietary blend hiding a collection of ineffective doses behind a single impressive number.

A product built the way I believe every supplement should be built, starting with the physiology and letting the formulation follow from there.

That is the twenty-year lesson. It took most of those years to find a context in which to act on it properly.

One more thing worth saying clearly: this formulation is not finished. Not because it is lacking (every ingredient is there for a reason and every dose is defensible) but because the science does not stop moving. New studies get published. New data emerges on bioavailability, on ingredient interactions, on mechanisms we did not fully understand when we made the original brief. When that data is compelling enough to warrant a change, we will make it. If a better form of an ingredient becomes available, we will use it. If a new ingredient clears a high enough clinical bar to earn inclusion, we will test it first and include it if it passes.

The Performance Stack: The Same Philosophy Applied to Both Ends

The same formulation process that produced Wulf Sleep produced Wulf Test, and the same logic that led to building a coordinated sleep system led to building The Performance Stack as a coordinated day-and-night system.

Sleep and testosterone are not separate problems. They are the same physiological loop. A formulation philosophy that takes the science seriously has no choice but to address both ends, which is why the Performance Stack exists, and why it was built the way it was built.

The science led there. We followed it.